NeuroFusion is introduced, an assistive reporter that surfaces this latent signal rather than overriding it: discriminative field-classifier heads over per-lesion features condition a fast, single-pass draft-then-review decoder on their committed outputs.
Abstract
A capable brain-MRI report generator can still be, in effect, diagnostically silent. When a multi-chain chain-of-thought (CoT) reporter built on a medical Mistral-7B backbone is evaluated on held-out cohorts, it names most meningiomas and almost all metastases"glioma"(diagnosis recall 0.44/0.07). Yet the answer is not absent from the model: a supervised linear probe applied to its frozen segmentation features recovers the three tumour cohorts at 0.82 macro-F$_1$ (5-fold cross-validation; chance $\approx$0.33). We introduce NeuroFusion, an assistive reporter that surfaces this latent signal rather than overriding it: discriminative field-classifier heads over per-lesion features condition a fast, single-pass draft-then-review decoder on their committed outputs. Built on the identical Mistral backbone, this restores the diagnosis (meningioma 0.92, metastasis 0.75) and wins 8 of 9 prose-content comparisons across three held-out cohorts (RaTEScore, RadGraph-F$_1$, GREEN; Holm-corrected paired BCa), with no significant loss on the ninth, at 5-6x lower latency ($\approx$80 vs. 457 s/case). A controlled negative result sharpens the mechanism: a learned diagnosis pin that overrides the decoder instead of merely informing it collapses out-of-distribution metastasis recall to 0.03. Grammar-constrained decoding keeps 92.3% of records schema-valid, making every sentence entailment-checkable (7.5% contradicted vs. 36.8% for the direct baseline). In a blinded nine-case pilot, two board-certified neurologists independently rated NeuroFusion highest in every tumour type, the only system with zero critical errors, and gave it the top-rated sign-off in eight of nine cases (six outright, two ties).
Reliable categorization of brain tumors from magnetic resonance imaging (MRI) is a prerequisite for timely clinical
intervention, yet the great majority of transfer-learning studies in this space report a single backbone in isolation, leaving open
the question of how much of the reported performance is attributable to...
Ganeshula Sai Raghava· International Journal for Re...· 0 citations
NeuroAttnFuseNet, a dual-path attention-guided fusion network for four-class MRI image classification into glioma, meningioma, pituitary, and no tumor, is proposed, indicating high image-level performance on the merged dataset.
Md Sanowar Hossain Sabuj, F. Sultana, Mahum Rashid et al.· Discover Artificial Intellig...· 0 citations
A brain tumor is a life-threatening disease that carries a high mortality burden. It can be treated if detected in the early stages. Manual analysis by a radiologist using Magnetic Resonance Imaging (MRI) is effective but slow and subject to inter-observer variability. In order to automate it, various deep learning mod...
J. Sahoo, Surendra Kumar Nanda, Ganapati Panda et al.· Bioengineering· 0 citations
Deep learning classifiers for breast cancer histology achieve expert-level accuracy but do not explain which tissue regions drove the diagnosis. We present
GRALIS-Report
, an attribution pipeline with two defining architectural properties:
raw images never enter the report generation stage
, and
no informati...
Many existing deep-learning models for brain-tumor diagnosis report very high accuracy, yet they often suffer from overfitting, limited generalizability, and poor robustness, which reduces their clinical reliability. First, a large and diverse dataset was assembled from multiple publicly available sources to reduce dat...
Mohammad Shahjahan Majib, Mahum Rashid, Md. Ashraful Haque et al.· Journal of Imaging· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.